> ## Content Index > Fetch the complete content index at: https://www.thescienceofstuff.com/llms.txt > Use this file to discover other available public pages before exploring further. # Is the NAD+ IV drip worth it? What longevity clinics are selling versus what the evidence shows - URL: https://www.thescienceofstuff.com/is-the-nad-iv-drip-worth-it-what-longevity-clinics-are-selling-versus-what-the-evidence-shows/ - Published: 2026-08-07T00:13:16.000Z - Updated: 2026-08-07T00:38:41.000Z - Author: SoS Staff - Tags: Treatments, Thin ## TL;DR NAD+ (nicotinamide adenine dinucleotide) is a real coenzyme that declines with age, and boosting it does interesting things in mice. But the IV drip specifically — the thing clinics are selling for hundreds of dollars a session — has almost no human trial data behind it. What data exists comes from oral precursors like NMN and NR, not intravenous NAD+ itself, and even those trials show modest, inconsistent effects on energy or metabolic markers, not reversed aging. If you're paying for an "anti-aging" IV drip, you're mostly paying for the infusion experience and the story, not a proven longevity intervention. ## What is NAD+ and why do clinics say it matters? NAD+ is a coenzyme every cell needs to run mitochondrial energy production and DNA repair. It's genuinely central to metabolism — that part isn't marketing. Levels do measurably drop with age; a widely cited paper by Imai and Guarente, "NAD+ and sirtuins in aging and disease" (*Trends in Cell Biology*, 2014), lays out the biology of why researchers got excited about this in the first place. The leap clinics make is from "NAD+ declines with age" to "so infusing it will slow your aging," which is a much bigger claim than the basic science supports. ## What does the human research actually show? Here's the catch: almost none of the human research is on IV NAD+. Most of the clinical trials use oral precursors — nicotinamide riboside (NR) or nicotinamide mononucleotide (NMN) — because NAD+ itself is poorly absorbed orally and hard to study cleanly even by infusion. A 2018 randomized trial by Martens et al., "Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults" (*Nature Communications*), found that NR supplementation did raise NAD+ levels in blood, and was safe over six weeks — but it didn't significantly improve insulin sensitivity, blood pressure, or other markers of "healthy aging" in that study. A separate small trial, Airhart et al. 2017 (published in *PLOS ONE*), tracked NR pharmacokinetics in humans and confirmed it's absorbed and raises NAD+ metabolites, but again didn't test functional outcomes like energy or cognition in any rigorous way. As for the IV route specifically: there is essentially no published randomized controlled trial testing intravenous NAD+ infusions against placebo for energy, cognition, or aging biomarkers in healthy adults. Most of what's circulating is case reports, addiction-treatment literature (NAD+ IVs were originally popularized in some substance-withdrawal clinics), and clinic-funded testimonials. That's a meaningfully different evidence tier than a peer-reviewed RCT. ## Why does the drip feel like it works? People often report feeling more alert or clear-headed during or right after an NAD+ infusion. Some of that plausibly involves the coenzyme's real role in cellular energy metabolism. But a two-hour IV drip also involves being hydrated, sitting still, off your phone, in a calm clinical setting — all of which independently make people feel better temporarily. Without a placebo-controlled comparison (saline drip, same setting, same duration), it's genuinely hard to separate "NAD+ did this" from "lying down and getting fluids did this." ## Are there risks or downsides? NAD+ infusions are generally described as well-tolerated, but they're not nothing: some people report flushing, nausea, chest tightness, or cramping during infusion, especially if it's pushed too fast. Because it's typically administered in medical-spa or wellness-clinic settings rather than hospitals, the IV itself carries the usual small risks of any infusion — infection at the site, vein irritation — and the product isn't FDA-approved as a drug for anti-aging use, so purity and dosing aren't standardized the way a prescription drug's would be. The bigger risk is financial and opportunity cost: repeated $300–$1,000 sessions add up fast for a benefit that's currently more assumed than demonstrated. ## How does IV NAD+ compare to oral NMN or NR supplements? Oral precursors are cheaper (often $30–$60/month), have more actual human trial data behind them (even if that data is modest), and can be taken indefinitely without a clinic visit. IV NAD+ theoretically bypasses the absorption limits of the oral route, which sounds like an advantage — but since nobody has run the head-to-head trial showing IV NAD+ produces better outcomes than oral precursors in healthy adults, that theoretical advantage hasn't been demonstrated to translate into a real one. If you're going to spend money chasing this pathway, the oral-precursor trials are the closest thing to an evidence base you actually have. ## FAQ **Q: Is NAD+ IV therapy FDA-approved for anti-aging?** A: No. NAD+ is not FDA-approved as a drug for anti-aging, energy, or longevity indications. Clinics offering it are operating outside an approved-indication framework, similar to many other IV "wellness" infusions. **Q: Will an NAD+ drip actually slow aging?** A: There's no human trial showing this. The aging-biology rationale is real and interesting, but it hasn't been tested with IV NAD+ in a rigorous, placebo-controlled way in healthy people. **Q: Is oral NMN or NR a better bet than the IV drip?** A: It's cheaper and has more (though still limited) human data, like the Martens et al. 2018 trial. "Better bet" is relative — neither has strong evidence for anti-aging outcomes yet, but oral precursors let you test the water without a four-figure monthly clinic bill. **Q: Why do people feel energized right after the infusion?** A: Possibly the NAD+ itself, possibly the hydration and rest during a slow IV session, possibly a placebo response to an expensive, ritualized treatment. No published trial has isolated which factor is doing the work. ## Sources - [Martens, C.R. et al. "Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults." Nature Communications, 2018.](https://pubmed.ncbi.nlm.nih.gov/29844486/?ref=thescienceofstuff.com) - [Airhart, S.E. et al. "An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers." PLOS ONE, 2017.](https://pubmed.ncbi.nlm.nih.gov/28934109/?ref=thescienceofstuff.com) - [Imai, S. and Guarente, L. "NAD+ and sirtuins in aging and disease." Trends in Cell Biology, 2014.](https://pubmed.ncbi.nlm.nih.gov/24521623/?ref=thescienceofstuff.com) --- **Medical Disclaimer** This content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making any health-related decisions or using any treatments discussed herein. Results vary by individual. ---